Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey

dc.authorid0000-0002-2049-1316
dc.contributor.authorTopal, İlteriş Oğuz
dc.contributor.authorTokmak, Aslı
dc.contributor.authorKurmuş, Gökçe Işıl
dc.contributor.authorKalkan, Göknur
dc.contributor.authorDemirseren, Düriye Deniz
dc.contributor.authorTosun, Mustafa
dc.contributor.authorEmre, Selma
dc.contributor.authorÖzkök Akbulut, Tuğba
dc.contributor.authorKaya Özden, Hatice
dc.contributor.authorKoska, Mahmut Can
dc.contributor.authorKülcü Çakmak, Seray
dc.contributor.authorKutlu, Ömer
dc.contributor.authorMutlu, Emine
dc.contributor.authorGür Aksoy, Güneş
dc.contributor.authorTopaloğlu Demir, Filiz
dc.contributor.authorKaradağ, Ayşe Serap
dc.date.accessioned2023-09-18T11:37:14Z
dc.date.available2023-09-18T11:37:14Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Deri ve Zührevi Hastalıklar Ana Bilim Dalı
dc.description.abstractPurpose: After the emergence of the pandemic caused by the COVID-19 virus, vaccination with various vaccines has started to be implemented across the world. To identify dermatological reactions developing after the COVID-19 vaccines administered in Turkey and determine their clinical features and risk factors that may play a role in their development. Materials and Methods: The study included patients aged ?18 years, who presented to 13 different dermatology clinics in Turkey between July 2021 and September 2021 after developing dermatological reactions following the administration of the COVID-19 vaccine. After providing written consent, the patients were asked to complete a standard survey including questions related to age, gender, occupation, comorbidities, the regular medication used, the onset of cutaneous reactions after vaccination, and localization of reactions. Dermatological reactions were categorized according to whether they developed after the first or second dose of the vaccine or whether they occurred after the inactivated or messenger RNA (mRNA) vaccine. The relationship between dermatological reactions and some variables such as gender and comorbidities was also evaluated. Results: A total of 269 patients [116 women (43.1%), 153 men (56.9%)] were included in the study. It was observed that the dermatological diseases and reactions that most frequently developed after vaccination were urticaria (25.7%), herpes zoster (24.9%), maculopapular eruption (12.3%), and pityriasis rosea (4.5%). The rate of dermatological reactions was 60.6% after the administration of the mRNA vaccine and 39.4% after that of the inactivated vaccine. There was a statistically significantly higher number of reactions among the patients that received the mRNA vaccine (p = 0.001). Conclusion: The most common reactions in our sample were urticaria, herpes zoster, and maculopapular eruption. Physicians should know the dermatological side effects of COVID-19 vaccines and their clinical features.
dc.identifier.citationTopal, İ. O., Tokmak, A., Kurmuş, G. I., Kalkan, G., Demirseren, D. D., Tosun, M. ... Karadağ, A. S. (2023). Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey. Journal of Cosmetic Dermatology, 22(2), 354-363. https://dx.doi.org/10.1111/jocd.15570
dc.identifier.doi10.1111/jocd.15570
dc.identifier.endpage363
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue2
dc.identifier.pmid36575896
dc.identifier.scopus2-s2.0-85145326250
dc.identifier.scopusqualityQ2
dc.identifier.startpage354
dc.identifier.urihttps://dx.doi.org/10.1111/jocd.15570
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11448
dc.identifier.volume22
dc.identifier.wos000903785000001en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTopaloğlu Demir, Filiz
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19
dc.subjectReactions
dc.subjectVaccine
dc.titleSkin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Demir-Filiz-2023.pdf
Boyut:
1.88 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: